Skip to Main Content

Paper Details

Early administration of COVID-19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy.
Am J Hematol
10
2022
Author NameAffiliation
Nicole VerdunCenter for Biologics Evaluation and Research
Michael J JoynerMayo Clinic
R. Scott WrightMayo Clinic
Rickey E CarterMayo Clinic
Peter W MarksCenter for Biologics Evaluation and Research
  • 1 - 5

Datasets

Release 1.2